ticagrelor is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Amneal Pharmaceuticals Ny Llc. The primary component is Ticagrelor.
| Product ID | 69238-1134_6f0b5544-07cf-476e-98dd-61a85dd3e492 |
| NDC | 69238-1134 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ticagrelor |
| Generic Name | Ticagrelor |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-01-23 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA208531 |
| Labeler Name | Amneal Pharmaceuticals NY LLC |
| Substance Name | TICAGRELOR |
| Active Ingredient Strength | 90 mg/1 |
| Pharm Classes | P2Y12 Platelet Inhibitor [EPC],Phenylalanine Hydroxylase Activators [MoA],Decreased Platelet Aggregation [PE],P2Y12 Receptor Antagonists [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A5 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2019-01-23 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA208531 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-01-23 |
| Marketing Category | ANDA |
| Application Number | ANDA208531 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-01-23 |
| Ingredient | Strength |
|---|---|
| TICAGRELOR | 90 mg/1 |
| SPL SET ID: | 7cee944f-e2ca-4fc8-bb97-f46ca28728c5 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 69238-1134 | ticagrelor | ticagrelor |
| 0186-0776 | BRILINTA | Ticagrelor |
| 0186-0777 | BRILINTA | Ticagrelor |
| 55154-9618 | BRILINTA | Ticagrelor |